HEADER FLUORESCENT PROTEIN 23-JUL-20 6ZUI TITLE CRYSTAL STRUCTURE OF THE CYS-SER MUTANT OF THE CPYFP-BASED BIOSENSOR TITLE 2 FOR HYPOCHLOROUS ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: HTH-TYPE TRANSCRIPTIONAL REPRESSOR NEMR,GREEN FLUORESCENT COMPND 3 PROTEIN,GREEN FLUORESCENT PROTEIN,HTH-TYPE TRANSCRIPTIONAL REPRESSOR COMPND 4 NEMR; COMPND 5 CHAIN: A; COMPND 6 SYNONYM: BLEACH-SENSING TRANSCRIPTION FACTOR,REDOX-REGULATED COMPND 7 TRANSCRIPTION FACTOR NEMR,BLEACH-SENSING TRANSCRIPTION FACTOR,REDOX- COMPND 8 REGULATED TRANSCRIPTION FACTOR NEMR; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 OTHER_DETAILS: THE PROTEIN CONTAINS A CHROMOPHORE (CR2 = GLY-TYR-GLY) COMPND 12 WITHIN THE CPYFP DOMAIN.,THE PROTEIN CONTAINS A CHROMOPHORE (CR2 = COMPND 13 GLY-TYR-GLY) WITHIN THE CPYFP DOMAIN.,THE PROTEIN CONTAINS A COMPND 14 CHROMOPHORE (CR2 = GLY-TYR-GLY) WITHIN THE CPYFP DOMAIN.,THE PROTEIN COMPND 15 CONTAINS A CHROMOPHORE (CR2 = GLY-TYR-GLY) WITHIN THE CPYFP DOMAIN. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI (STRAIN K12), AEQUOREA SOURCE 3 VICTORIA; SOURCE 4 ORGANISM_COMMON: JELLYFISH; SOURCE 5 ORGANISM_TAXID: 83333, 6100; SOURCE 6 STRAIN: K12; SOURCE 7 GENE: NEMR, YDHM, B1649, JW5874, GFP; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BIOSENSOR, HYPOHALOUS ACID, CPYFP, YELLOW FLUORESCENT PROTEIN, KEYWDS 2 FLUORESCENT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.A.TOSSOUNIAN,I.VAN MOLLE,J.MESSENS REVDAT 3 31-JAN-24 6ZUI 1 JRNL REVDAT 2 19-JAN-22 6ZUI 1 JRNL REMARK REVDAT 1 30-JUN-21 6ZUI 0 JRNL AUTH A.I.KOSTYUK,M.A.TOSSOUNIAN,A.S.PANOVA,M.THAUVIN, JRNL AUTH 2 R.I.RAEVSKII,D.EZERINA,K.WAHNI,I.VAN MOLLE,A.D.SERGEEVA, JRNL AUTH 3 D.VERTOMMEN,A.Y.GOROKHOVATSKY,M.S.BARANOV,S.VRIZ,J.MESSENS, JRNL AUTH 4 D.S.BILAN,V.V.BELOUSOV JRNL TITL HYPOCRATES IS A GENETICALLY ENCODED FLUORESCENT BIOSENSOR JRNL TITL 2 FOR (PSEUDO)HYPOHALOUS ACIDS AND THEIR DERIVATIVES. JRNL REF NAT COMMUN V. 13 171 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 35013284 JRNL DOI 10.1038/S41467-021-27796-2 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.I.KOSTYUK,M.A.TOSSOUNIAN,A.S.PANOVA,M.THAUVIN,K.WAHNI, REMARK 1 AUTH 2 I.VAN MOLLE,R.I.RAEVSKII,M.S.BARANOV,S.VRIZ,J.MESSENS, REMARK 1 AUTH 3 D.S.BILAN,V.V.BELOUSOV REMARK 1 TITL MONITORING OXIDATIVE INFLAMMATORY PROCESSES IN LIVE CELLS REMARK 1 TITL 2 AND TISSUE WITH HYPOCRATES, A GENETICALLY ENCODED BIOSENSOR REMARK 1 TITL 3 FOR HYPOCHLORITE REMARK 1 REF BIORXIV 2021 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2021.02.22.432222 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.72 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.338 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 22261 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.103 REMARK 3 FREE R VALUE TEST SET COUNT : 1136 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.7185 - 4.3992 0.90 2633 152 0.1666 0.2336 REMARK 3 2 4.3992 - 3.4921 0.94 2643 142 0.1662 0.2168 REMARK 3 3 3.4921 - 3.0507 0.95 2697 109 0.2045 0.2769 REMARK 3 4 3.0507 - 2.7718 0.96 2652 155 0.2316 0.3436 REMARK 3 5 2.7718 - 2.5732 0.97 2663 168 0.2236 0.3035 REMARK 3 6 2.5732 - 2.4215 0.97 2708 121 0.2343 0.3255 REMARK 3 7 2.4215 - 2.3002 0.97 2670 162 0.2589 0.3532 REMARK 3 8 2.3002 - 2.2001 0.89 2459 127 0.2853 0.3907 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.970 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 3386 REMARK 3 ANGLE : 1.004 4567 REMARK 3 CHIRALITY : 0.048 498 REMARK 3 PLANARITY : 0.004 594 REMARK 3 DIHEDRAL : 6.094 2787 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZUI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1292109446. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980113 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22368 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 47.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.0 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.62000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YZE, 3O77 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS (0.1 M, PH 8), CACL2 (0.1 M), REMARK 280 MGCL2 (0.1 M) AND PE15/4 (15%) PROTEIN CONCENTRATION:7 MG/ML, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 283.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.12300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.12300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.11600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.71850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.11600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.71850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.12300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.11600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.71850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 53.12300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.11600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.71850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 662 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 LYS A 3 REMARK 465 HIS A 4 REMARK 465 THR A 5 REMARK 465 GLU A 6 REMARK 465 HIS A 7 REMARK 465 PRO A 41 REMARK 465 LYS A 42 REMARK 465 GLY A 43 REMARK 465 GLY A 193 REMARK 465 MET A 194 REMARK 465 ASP A 195 REMARK 465 GLU A 196 REMARK 465 LEU A 197 REMARK 465 TYR A 198 REMARK 465 ASN A 199 REMARK 465 VAL A 200 REMARK 465 ASP A 201 REMARK 465 GLY A 202 REMARK 465 GLY A 203 REMARK 465 SER A 204 REMARK 465 GLY A 205 REMARK 465 GLY A 206 REMARK 465 THR A 207 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 339 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 45 -60.00 52.93 REMARK 500 SER A 98 74.72 58.87 REMARK 500 ASP A 116 73.92 -119.31 REMARK 500 ILE A 343 -64.13 -91.31 REMARK 500 SER A 365 -68.40 164.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG A 303 THR A 304 148.48 REMARK 500 REMARK 500 REMARK: NULL DBREF 6ZUI A 1 102 UNP P67430 NEMR_ECOLI 1 102 DBREF 6ZUI A 106 198 UNP P42212 GFP_AEQVI 145 237 DBREF 6ZUI A 209 351 UNP P42212 GFP_AEQVI 2 144 DBREF 6ZUI A 354 448 UNP P67430 NEMR_ECOLI 105 199 SEQADV 6ZUI SER A 21 UNP P67430 CYS 21 ENGINEERED MUTATION SEQADV 6ZUI SER A 98 UNP P67430 CYS 98 ENGINEERED MUTATION SEQADV 6ZUI SER A 103 UNP P67430 LINKER SEQADV 6ZUI ALA A 104 UNP P67430 LINKER SEQADV 6ZUI GLY A 105 UNP P67430 LINKER SEQADV 6ZUI ASP A 109 UNP P42212 HIS 148 ENGINEERED MUTATION SEQADV 6ZUI ALA A 124 UNP P42212 VAL 163 ENGINEERED MUTATION SEQADV 6ZUI VAL A 132 UNP P42212 ILE 171 ENGINEERED MUTATION SEQADV 6ZUI PHE A 164 UNP P42212 THR 203 ENGINEERED MUTATION SEQADV 6ZUI VAL A 167 UNP P42212 ALA 206 ENGINEERED MUTATION SEQADV 6ZUI LEU A 192 UNP P42212 HIS 231 ENGINEERED MUTATION SEQADV 6ZUI ASN A 199 UNP P42212 LINKER SEQADV 6ZUI VAL A 200 UNP P42212 LINKER SEQADV 6ZUI ASP A 201 UNP P42212 LINKER SEQADV 6ZUI GLY A 202 UNP P42212 LINKER SEQADV 6ZUI GLY A 203 UNP P42212 LINKER SEQADV 6ZUI SER A 204 UNP P42212 LINKER SEQADV 6ZUI GLY A 205 UNP P42212 LINKER SEQADV 6ZUI GLY A 206 UNP P42212 LINKER SEQADV 6ZUI THR A 207 UNP P42212 LINKER SEQADV 6ZUI GLY A 208 UNP P42212 LINKER SEQADV 6ZUI LEU A 253 UNP P42212 PHE 46 ENGINEERED MUTATION SEQADV 6ZUI LEU A 271 UNP P42212 PHE 64 ENGINEERED MUTATION SEQADV 6ZUI CR2 A 273 UNP P42212 SER 65 CHROMOPHORE SEQADV 6ZUI A UNP P42212 TYR 66 CHROMOPHORE SEQADV 6ZUI A UNP P42212 GLY 67 CHROMOPHORE SEQADV 6ZUI LEU A 275 UNP P42212 VAL 68 ENGINEERED MUTATION SEQADV 6ZUI LYS A 276 UNP P42212 GLN 69 ENGINEERED MUTATION SEQADV 6ZUI ALA A 279 UNP P42212 SER 72 ENGINEERED MUTATION SEQADV 6ZUI GLY A 336 UNP P42212 ASP 129 ENGINEERED MUTATION SEQADV 6ZUI GLY A 352 UNP P42212 LINKER SEQADV 6ZUI THR A 353 UNP P42212 LINKER SEQADV 6ZUI SER A 355 UNP P67430 CYS 106 ENGINEERED MUTATION SEQADV 6ZUI SER A 365 UNP P67430 CYS 116 ENGINEERED MUTATION SEQADV 6ZUI SER A 398 UNP P67430 CYS 149 ENGINEERED MUTATION SEQADV 6ZUI SER A 402 UNP P67430 CYS 153 ENGINEERED MUTATION SEQRES 1 A 446 MET ASN LYS HIS THR GLU HIS ASP THR ARG GLU HIS LEU SEQRES 2 A 446 LEU ALA THR GLY GLU GLN LEU SER LEU GLN ARG GLY PHE SEQRES 3 A 446 THR GLY MET GLY LEU SER GLU LEU LEU LYS THR ALA GLU SEQRES 4 A 446 VAL PRO LYS GLY SER PHE TYR HIS TYR PHE ARG SER LYS SEQRES 5 A 446 GLU ALA PHE GLY VAL ALA MET LEU GLU ARG HIS TYR ALA SEQRES 6 A 446 ALA TYR HIS GLN ARG LEU THR GLU LEU LEU GLN SER GLY SEQRES 7 A 446 GLU GLY ASN TYR ARG ASP ARG ILE LEU ALA TYR TYR GLN SEQRES 8 A 446 GLN THR LEU ASN GLN PHE SER GLN HIS GLY THR SER ALA SEQRES 9 A 446 GLY TYR ASN SER ASP ASN VAL TYR ILE MET ALA ASP LYS SEQRES 10 A 446 GLN LYS ASN GLY ILE LYS ALA ASN PHE LYS ILE ARG HIS SEQRES 11 A 446 ASN VAL GLU ASP GLY SER VAL GLN LEU ALA ASP HIS TYR SEQRES 12 A 446 GLN GLN ASN THR PRO ILE GLY ASP GLY PRO VAL LEU LEU SEQRES 13 A 446 PRO ASP ASN HIS TYR LEU SER PHE GLN SER VAL LEU SER SEQRES 14 A 446 LYS ASP PRO ASN GLU LYS ARG ASP HIS MET VAL LEU LEU SEQRES 15 A 446 GLU PHE VAL THR ALA ALA GLY ILE THR LEU GLY MET ASP SEQRES 16 A 446 GLU LEU TYR ASN VAL ASP GLY GLY SER GLY GLY THR GLY SEQRES 17 A 446 SER LYS GLY GLU GLU LEU PHE THR GLY VAL VAL PRO ILE SEQRES 18 A 446 LEU VAL GLU LEU ASP GLY ASP VAL ASN GLY HIS LYS PHE SEQRES 19 A 446 SER VAL SER GLY GLU GLY GLU GLY ASP ALA THR TYR GLY SEQRES 20 A 446 LYS LEU THR LEU LYS LEU ILE CYS THR THR GLY LYS LEU SEQRES 21 A 446 PRO VAL PRO TRP PRO THR LEU VAL THR THR LEU CR2 LEU SEQRES 22 A 446 LYS CYS PHE ALA ARG TYR PRO ASP HIS MET LYS GLN HIS SEQRES 23 A 446 ASP PHE PHE LYS SER ALA MET PRO GLU GLY TYR VAL GLN SEQRES 24 A 446 GLU ARG THR ILE PHE PHE LYS ASP ASP GLY ASN TYR LYS SEQRES 25 A 446 THR ARG ALA GLU VAL LYS PHE GLU GLY ASP THR LEU VAL SEQRES 26 A 446 ASN ARG ILE GLU LEU LYS GLY ILE GLY PHE LYS GLU ASP SEQRES 27 A 446 GLY ASN ILE LEU GLY HIS LYS LEU GLU TYR ASN GLY THR SEQRES 28 A 446 GLY SER LEU THR VAL LYS LEU SER ALA GLU VAL SER ASP SEQRES 29 A 446 LEU SER GLU ASP MET ARG SER ALA MET ASP LYS GLY ALA SEQRES 30 A 446 ARG GLY VAL ILE ALA LEU LEU SER GLN ALA LEU GLU ASN SEQRES 31 A 446 GLY ARG GLU ASN HIS SER LEU THR PHE SER GLY GLU PRO SEQRES 32 A 446 LEU GLN GLN ALA GLN VAL LEU TYR ALA LEU TRP LEU GLY SEQRES 33 A 446 ALA ASN LEU GLN ALA LYS ILE SER ARG SER PHE GLU PRO SEQRES 34 A 446 LEU GLU ASN ALA LEU ALA HIS VAL LYS ASN ILE ILE ALA SEQRES 35 A 446 THR PRO ALA VAL MODRES 6ZUI CR2 A 273 SER CHROMOPHORE HET CR2 A 273 19 HETNAM CR2 {(4Z)-2-(AMINOMETHYL)-4-[(4-HYDROXYPHENYL)METHYLIDENE]- HETNAM 2 CR2 5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETIC ACID HETSYN CR2 CHROMOPHORE (GLY-TYR-GLY) FORMUL 1 CR2 C13 H13 N3 O4 FORMUL 2 HOH *185(H2 O) HELIX 1 AA1 ASP A 8 GLY A 25 1 18 HELIX 2 AA2 GLY A 30 GLU A 39 1 10 HELIX 3 AA3 SER A 51 GLY A 78 1 28 HELIX 4 AA4 ASN A 81 GLN A 92 1 12 HELIX 5 AA5 HIS A 100 ALA A 104 5 5 HELIX 6 AA6 LYS A 117 ASN A 120 5 4 HELIX 7 AA7 LYS A 210 THR A 216 5 7 HELIX 8 AA8 PRO A 263 VAL A 268 5 6 HELIX 9 AA9 LEU A 275 ALA A 279 5 5 HELIX 10 AB1 PRO A 282 HIS A 288 5 7 HELIX 11 AB2 ASP A 289 ALA A 294 1 6 HELIX 12 AB3 SER A 355 ALA A 362 1 8 HELIX 13 AB4 SER A 368 ASN A 396 1 29 HELIX 14 AB5 GLU A 404 ARG A 427 1 24 HELIX 15 AB6 PHE A 429 ILE A 443 1 15 SHEET 1 AA112 ASP A 109 ASP A 116 0 SHEET 2 AA112 GLY A 121 ASN A 131 -1 O GLY A 121 N ASP A 116 SHEET 3 AA112 VAL A 137 PRO A 148 -1 O GLN A 144 N ALA A 124 SHEET 4 AA112 TYR A 299 PHE A 307 -1 O VAL A 300 N THR A 147 SHEET 5 AA112 ASN A 312 GLU A 322 -1 O TYR A 313 N ILE A 305 SHEET 6 AA112 THR A 325 ILE A 335 -1 O VAL A 327 N LYS A 320 SHEET 7 AA112 VAL A 218 VAL A 229 1 N GLU A 224 O ILE A 330 SHEET 8 AA112 HIS A 232 ASP A 243 -1 O PHE A 234 N GLY A 227 SHEET 9 AA112 LYS A 248 CYS A 255 -1 O LYS A 248 N ASP A 243 SHEET 10 AA112 HIS A 178 ALA A 188 -1 N MET A 179 O LEU A 253 SHEET 11 AA112 HIS A 160 SER A 169 -1 N SER A 163 O THR A 186 SHEET 12 AA112 ASP A 109 ASP A 116 -1 N ASP A 109 O PHE A 164 LINK C LEU A 271 N1 CR2 A 273 1555 1555 1.48 LINK C3 CR2 A 273 N LEU A 275 1555 1555 1.71 CISPEP 1 MET A 295 PRO A 296 0 8.70 CRYST1 90.232 95.437 106.246 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011083 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010478 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009412 0.00000